Pfizer Receives FDA Approval for Prevnar 13 in Adults Age 18 Through 49

July 12, 2016 - Pfizer Inc. (NYSE:PFE) today announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S. Food and Drug Administration (FDA) approval for an expanded age indication to include adults...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news